University of California, San Francisco | UCSF Memory and Aging Center

Research site
675 Nelson Rising Lane, Suite 190, San Francisco, California, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


4 of 17
Status: Active
Trial type: Interventional
Funder type: Industry

A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease (INVOKE-2)

A phase 2 randomized, double blind, placebo controlled study evaluating the efficacy and safety of AL002 in participants with Early Alzheimer's Disea...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: AL002

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

To find out the effect of Lu AF82422 on disease progression in participants with multiple system atrophy.

Active, not recruiting
Multiple System Atrophy
Drug: Placebo
Drug: Lu AF82422

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab
Drug: Placebo

Trial conditions

Alzheimer Disease (7 trials)
Frontotemporal Dementia (3 trials)
Pick Disease of the Brain (3 trials)
Primary Progressive Apha... (3 trials)
Atrophy (2 trials)
Cognitive Dysfunction (2 trials)
Multiple System Atrophy (2 trials)
Shy-Drager Syndrome (2 trials)
Aphasia (1 trial)
Brain Diseases (1 trial)

And 10 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems